Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil P Shah

Showing results (11-20 of 119) with videos related to

Pageof 12
Sort By:
Hematology. American Society of Hematology. Education Program|November 21, 2007
Medical management of CMLNeil P Shah
Blood|November 7, 2024
The promise of allosteric kinase inhibitionNeil P Shah
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 4, 2013
What does a deep molecular response signify?Julieta Politi, Neil P Shah
Blood|April 14, 2012
Advancing the STATus of MPN pathogenesisNeil P Shah, Kevin Shannon
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2013
The role of kinase inhibitors in the treatment of patients with acute myeloid leukemiaCatherine C Smith, Neil P Shah
Chemistry & Biology|June 25, 2013
Ins and outs of kinase DFG motifsDaniel K Treiber, Neil P Shah
Hematology. American Society of Hematology. Education Program|December 14, 2011
Tyrosine kinase inhibitor therapy for chronic myeloid leukemia: approach to patients with treatment-naive or refractory chronic-phase diseaseCatherine C Smith, Neil P Shah
Cancer Cell|October 14, 2015
PPARγ: Welcoming the New Kid on the CML Stem Cell BlockBeth Apsel Winger, Neil P Shah
Oncogene|October 25, 2003
Mechanisms of resistance to STI571 in Philadelphia chromosome-associated leukemiasNeil P Shah, Charles L Sawyers
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2011
Is it downhill from here? Eliminating leukemic stem cells and curing chronic myeloid leukemiaCatherine C Smith, Neil P Shah
Pageof 12

Showing results (11-20 of 119) with videos related to

Sort By:
Pageof 12
Hematology. American Society of Hematology. Education Program|November 21, 2007
Medical management of CMLNeil P Shah
Blood|November 7, 2024
The promise of allosteric kinase inhibitionNeil P Shah
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 4, 2013
What does a deep molecular response signify?Julieta Politi, Neil P Shah
Blood|April 14, 2012
Advancing the STATus of MPN pathogenesisNeil P Shah, Kevin Shannon
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2013
The role of kinase inhibitors in the treatment of patients with acute myeloid leukemiaCatherine C Smith, Neil P Shah
Chemistry & Biology|June 25, 2013
Ins and outs of kinase DFG motifsDaniel K Treiber, Neil P Shah
Hematology. American Society of Hematology. Education Program|December 14, 2011
Tyrosine kinase inhibitor therapy for chronic myeloid leukemia: approach to patients with treatment-naive or refractory chronic-phase diseaseCatherine C Smith, Neil P Shah
Cancer Cell|October 14, 2015
PPARγ: Welcoming the New Kid on the CML Stem Cell BlockBeth Apsel Winger, Neil P Shah
Oncogene|October 25, 2003
Mechanisms of resistance to STI571 in Philadelphia chromosome-associated leukemiasNeil P Shah, Charles L Sawyers
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2011
Is it downhill from here? Eliminating leukemic stem cells and curing chronic myeloid leukemiaCatherine C Smith, Neil P Shah
Pageof 12